v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance, shares at Dec. 31, 2023   5,581,153      
Beginning balance at Dec. 31, 2023 $ 51,099 $ 6 $ 529,117 $ (119) $ (477,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   16,773      
Vesting of restricted stock units 0        
Stock-based compensation expense 1,739   1,739    
Unrealized loss on marketable securities (36)     (36)  
Net loss (51,766)       (51,766)
Ending balance, shares at Mar. 31, 2024   5,597,926      
Ending balance at Mar. 31, 2024 1,036 $ 6 530,856 (155) (529,671)
Beginning balance, shares at Dec. 31, 2023   5,581,153      
Beginning balance at Dec. 31, 2023 51,099 $ 6 529,117 (119) (477,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 39,067        
Ending balance, shares at Jun. 30, 2024   5,606,538      
Ending balance at Jun. 30, 2024 94,451 $ 6 533,442 (159) (438,838)
Beginning balance, shares at Mar. 31, 2024   5,597,926      
Beginning balance at Mar. 31, 2024 1,036 $ 6 530,856 (155) (529,671)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   777      
Vesting of restricted stock units 0        
Issuance of shares of common stock under employee stock purchase plan (in shares)   7,835      
Issuance of common stock under employee stock purchase plan 158   158    
Stock-based compensation expense 2,428   2,428    
Unrealized loss on marketable securities (4)     (4)  
Net loss 90,833       90,833
Ending balance, shares at Jun. 30, 2024   5,606,538      
Ending balance at Jun. 30, 2024 94,451 $ 6 533,442 (159) (438,838)
Beginning balance, shares at Dec. 31, 2024   5,698,231      
Beginning balance at Dec. 31, 2024 22,149 $ 6 537,620 (122) (515,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   90,514      
Vesting of restricted stock units 0        
Stock-based compensation expense 519   519    
Unrealized loss on marketable securities (6)     (6)  
Net loss 282       282
Ending balance, shares at Mar. 31, 2025   5,788,745      
Ending balance at Mar. 31, 2025 22,944 $ 6 538,139 (128) (515,073)
Beginning balance, shares at Dec. 31, 2024   5,698,231      
Beginning balance at Dec. 31, 2024 22,149 $ 6 537,620 (122) (515,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (25,459)        
Ending balance, shares at Jun. 30, 2025   7,959,947      
Ending balance at Jun. 30, 2025 3,971 $ 8 544,915 (138) (540,814)
Beginning balance, shares at Mar. 31, 2025   5,788,745      
Beginning balance at Mar. 31, 2025 22,944 $ 6 538,139 (128) (515,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Proceeds from the sale of stock, less discounts (in shares)   2,140,729      
Proceeds from the sale of common stock, less discounts 5,984 $ 2 5,982    
Vesting of restricted stock units (in shares)   12,000      
Vesting of restricted stock units 0        
Issuance of shares of common stock under employee stock purchase plan (in shares)   18,473      
Issuance of common stock under employee stock purchase plan 46   46    
Stock-based compensation expense 748   748    
Unrealized loss on marketable securities (10)     (10)  
Net loss (25,741)       (25,741)
Ending balance, shares at Jun. 30, 2025   7,959,947      
Ending balance at Jun. 30, 2025 $ 3,971 $ 8 $ 544,915 $ (138) $ (540,814)